Evidence map›Paper›PMID 27178349›Full record

ArticleImmunologic research2016

The role of HSP27 in RACK1-mediated PKC activation in THP-1 cells.

Emanuela Corsini, Valentina Galbiati, Angela Papale, Elena Kummer, Antonella Pinto, Antonio Guaita, Marco Racchi

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Emanuela CorsiniLaboratory of Toxicology, DiSFeB, Università degli Studi di Milano, Milan, Italy.
Valentina GalbiatiLaboratory of Toxicology, DiSFeB, Università degli Studi di Milano, Milan, Italy.
Angela PapaleLaboratory of Toxicology, DiSFeB, Università degli Studi di Milano, Milan, Italy.
Elena KummerLaboratory of Toxicology, DiSFeB, Università degli Studi di Milano, Milan, Italy.
Antonella PintoDepartment of Drug Sciences - Pharmacology, University of Pavia, Viale Taramelli 14, 27100, Pavia, Italy.
Antonio Guaita"Golgi Cenci" Foundation, Abbiategrasso, Italy.
Marco RacchiDepartment of Drug Sciences - Pharmacology, University of Pavia, Viale Taramelli 14, 27100, Pavia, Italy. racchi@unipv.it.
University of Milan · ITUniversity of Pavia · ITFondazione Golgi Cenci · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor for Activated C Kinase 1 (RACK1) pseudosubstrate is a commercially available peptide that directly activates protein kinase C-β (PKCβ). We have recently shown that RACK1 pseudosubstrate, alone or in combination with classical immune activators, results in increased cytokine production and CD86 upregulation in primary leukocytes. Furthermore, we demonstrated a role of PKCβ and RACK1 in chemical allergen-induced CD86 expression and IL-8 production in both THP-1 cells and primary human dendritic cells. Aim of this study was to shed light on the mechanisms underlying RACK1 pseudosubstrate-induced immune activation and to compare it to lipopolysaccharide (LPS). The human promyelocytic cell line THP-1 was used throughout the study. RACK1 pseudosubstrate induced rapid (5 min) and dose-related PKCβ activation as assessed by its membrane translocation. Among the proteins phosphorylated, we identified Hsp27. Both RACK1 pseudosubstrate and LPS induce its phosphorylation and release in culture medium. The release of Hsp27 induced by RACK1 pseudosubstrate was also confirmed in peripheral blood mononuclear cells. To evaluate the role of Hsp27 in RACK1 pseudosubstrate or LPS-induced cell activation, we conducted Hsp27 silencing and neutralization experiments. Both strategies confirmed the central role of Hsp27 in RACK1 pseudosubstrate or LPS-induced cell activation, as assessed by IL-8 production and upregulation of CD86.

Indexed as

B7-2 AntigenHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansInterleukin-8Leukocytes, MononuclearLipopolysaccharidesMolecular ChaperonesNeoplasm ProteinsPhosphorylationProtein Kinase C betaReceptors for Activated C KinaseRNA, Small InterferingTHP-1 CellsUp-RegulationB7-2 AntigenHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHSPB1 protein, humanInterleukin-8LipopolysaccharidesMolecular ChaperonesNeoplasm ProteinsProtein Kinase C betaRACK1 protein, humanReceptors for Activated C KinaseRNA, Small InterferingCD86CytokinesmRNA stabilityPKCRACK1

Identifiers

PMID27178349
OpenAlexW2369871890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.